CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
NCT03152708 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 62
Last updated 2017-09-21
Summary
This study was conducted on the post-operative tumor tissues from 62 GBM patients. 20 slices are necessary for all the CD95 and CpG2 test in the central lab by the methods of immunisation and DNA methylation.
Conditions
Sponsors & Collaborators
-
CANbridge Life Sciences Ltd.
lead INDUSTRY
Principal Investigators
-
Jinsong Wu, MD · Huashan Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-01
- Primary Completion
- 2017-12-01
- Completion
- 2017-12-31
More Related Trials
-
Biomarker Analysis of Central Nervous System Tumors
NCT02692898 ·Status: TERMINATED
-
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
NCT03596593 ·Status: UNKNOWN ·Phase: NA
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Early Diagnosis of Oral Cancer by Detecting p16 Methylation
NCT01695018 ·Status: COMPLETED
-
Pan-canceR Early DetectIon projeCT (PREDICT)
NCT04817306 ·Status: UNKNOWN
-
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
NCT01365962 ·Status: COMPLETED
-
MRI and Metabolomics Biomarkers for Uterine Malignancy
NCT02528864 ·Status: COMPLETED
-
Biomarkers in Patients With Rhabdomyosarcoma
NCT01466283 ·Status: COMPLETED
-
Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
NCT05693012 ·Status: UNKNOWN
-
AssesSment of Early deteCtion basEd oN liquiD Biopsy in Intracranial Tumors
NCT05679089 ·Status: UNKNOWN
-
Study of Blood and Cheek Cell Samples From Patients With Glioma
NCT01009307 ·Status: COMPLETED
-
Biomarkers in Young Patients With Neuroblastoma
NCT01169376 ·Status: COMPLETED
-
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
NCT01553175 ·Status: COMPLETED
-
Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples
NCT01650922 ·Status: COMPLETED
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis
NCT03029065 ·Status: UNKNOWN
-
The Pathogenesis and Prognostic Factors of Lymphoma
NCT06203652 ·Status: RECRUITING
-
Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens
NCT03719222 ·Status: UNKNOWN
-
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
NCT03071913 ·Status: COMPLETED
-
Genetic Analysis of Brain Tumors
NCT00031538 ·Status: TERMINATED
-
Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer
NCT04947995 ·Status: UNKNOWN
-
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
NCT01493830 ·Status: COMPLETED
-
Biomarker Analysis of Gastrointestinal Cancer
NCT01484444 ·Status: UNKNOWN
-
Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab
NCT03919539 ·Status: UNKNOWN
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN